🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well everolimus and hormone therapy work in...
Status
Terminated
Location
Emory University Hospital Midtown
Start Date
2014-11-25
Trial ID
NCT02269670
Treatments Being Tested
This trial evaluated the efficacy of an everolimus-based quadruple low immu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02-01
Trial ID
NCT01404325
Treatments Being Tested
RAD001 is approved by the U.S Food and Drug Administration (FDA) to treat a...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2010-02
Trial ID
NCT01058408
Treatments Being Tested
The goal of this clinical research study is to see if RAD001 can help to co...
Status
Completed
Location
The University of Texas M.D. Anderson Cancer Center
Start Date
2007-04
Trial ID
NCT00449748
Treatments Being Tested
The purpose of this study is to see the safety and activity of using pasire...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2011-12
Trial ID
NCT01469572
Treatments Being Tested
The purpose of this study is to learn what effects, good and/or bad, Everol...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-12-05
Trial ID
NCT00805129
Treatments Being Tested
To evaluate the preliminary efficacy and safety of RAD001 as monotherapy fo...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00688753
Treatments Being Tested
This is an open-label, mono-center phase I/II study designed to determine t...
Status
Unknown
Location
Charité, university medicine, Berlin, CCM
Start Date
2009-02
Trial ID
NCT00930475
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00423865
The purpose of this study is to determine if RAD001 (everolimus) helps impr...
Status
Completed
Location
Ingalls Cancer Research Center
Start Date
2009-07
Trial ID
NCT00849550
Treatments Being Tested